Feed Preview

Fast Growing

Computation Neuroscience - Preprints (MDS)

Computation Neuroscience - Preprints (MDS) diagram by Franco Pestilli, PLOS Biology
Franco Pestilli, PLOS Biology

Computation neuroscience employs models, statistics, simulations, and theoretical analyses to understand mechanisms that govern neural functions. Here are the latest preprints in this domain.

Top 20 most recent papers
bioRxiv

Individual differences among deep neural network models

bioRxivJanuary 9, 2020
Johannes MehrerTim C Kietzmann
111
bioRxiv

A Bayesian Generative Model of Vestibular Afferent Neuron Spiking

bioRxivFebruary 4, 2020
Michael PaulinKiri F. Pullar
bioRxiv

Learning prediction error neurons in a canonical interneuron circuit

bioRxivFebruary 28, 2020
Loreen Hertäg, Henning Sprekeler
26
bioRxiv

Fronto-striatal projections regulate approach-avoidance conflict

bioRxivMarch 6, 2020
Adrienne C. LoewkeLisa A. Gunaydin
63
1
9
bioRxiv

Intratumor Heterogeneity and Evolution of Colorectal Cancer

bioRxivJanuary 19, 2020
Santasree BanerjeeXin Liu
5
bioRxiv

Restriction Enzyme Based Enriched L1Hs sequencing (REBELseq)

bioRxivJuly 20, 2019
Benjamin C ReinerWade H Berrettini
4
bioRxiv

Behavioral signatures of a developing neural code

bioRxivNovember 27, 2019
Lilach AvitanGeoffrey Goodhill
18

See more papers from this feed

Related Feeds

Allen Institute for Brain Science Network (MDS)

The Allen Institute for Brain Science Network is a not-for-profit biomedical research organization that provides open access to multiple neuroscience tools and resources. Find the latest research from tjr Allen Institute for Brain Science Network here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Antibody Therapeutics (MDS)

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. They have also been detected in several other neurodegenerative diseases, known as synucleopathies. Here is the latest research on alpha-synuclein antibody therapeutics.

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Autophagy: Cancer & Parkinson (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

BRAIN Initiative Cell Census Network (MDS)

The BRAIN Initiative Cell Census Network aims to identify and provide experimental access to the different brain cell types to determine their roles in health and disease. Discover the latest research from researchers in the BRAIN Initiative Cell Census Network here.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/computation-neuroscience---preprints/4f564f55-9879-466a-a424-c876876e226f